Suppr超能文献

计算证据表明,喹啉和喹啉 N-氧化物的硝基衍生物可作为治疗 SARS-CoV-2 感染的低成本替代品。

Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection.

机构信息

Department of Chemistry, Federal University of Lavras, Lavras, Minas Gerais, CEP 37200-000, Brazil.

Laboratório de Nanotecnologia E Química Computacional, Universidade Tecnológica Federal Do Paraná, Londrina, PR, 86036-370, Brazil.

出版信息

Sci Rep. 2021 Mar 18;11(1):6397. doi: 10.1038/s41598-021-85280-9.

Abstract

A new and more aggressive strain of coronavirus, known as SARS-CoV-2, which is highly contagious, has rapidly spread across the planet within a short period of time. Due to its high transmission rate and the significant time-space between infection and manifestation of symptoms, the WHO recently declared this a pandemic. Because of the exponentially growing number of new cases of both infections and deaths, development of new therapeutic options to help fight this pandemic is urgently needed. The target molecules of this study were the nitro derivatives of quinoline and quinoline N-oxide. Computational design at the DFT level, docking studies, and molecular dynamics methods as a well-reasoned strategy will aid in elucidating the fundamental physicochemical properties and molecular functions of a diversity of compounds, directly accelerating the process of discovering new drugs. In this study, we discovered isomers based on the nitro derivatives of quinoline and quinoline N-oxide, which are biologically active compounds and may be low-cost alternatives for the treatment of infections induced by SARS-CoV-2.

摘要

一种新型且更具侵略性的冠状病毒,称为 SARS-CoV-2,其具有很强的传染性,在短时间内迅速在全球范围内传播。由于其高传播率以及从感染到出现症状之间的显著时空间隔,世界卫生组织(WHO)最近宣布这是一种大流行。由于感染和死亡的新病例数量呈指数级增长,因此迫切需要开发新的治疗方法来帮助对抗这种大流行。本研究的靶分子是喹啉和喹啉 N-氧化物的硝基衍生物。在 DFT 水平上进行计算设计、对接研究和分子动力学方法作为合理的策略,将有助于阐明各种化合物的基本物理化学性质和分子功能,直接加速新药发现的过程。在这项研究中,我们发现了基于喹啉和喹啉 N-氧化物的硝基衍生物的异构体,这些化合物是具有生物活性的化合物,可能是治疗由 SARS-CoV-2 引起的感染的低成本替代品。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc7f/7973710/15553107e559/41598_2021_85280_Fig1_HTML.jpg

相似文献

2
New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.
Bioorg Chem. 2021 Sep;114:105117. doi: 10.1016/j.bioorg.2021.105117. Epub 2021 Jun 23.
6
Virtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication.
J Biomol Struct Dyn. 2022 Nov;40(18):8464-8493. doi: 10.1080/07391102.2021.1913228. Epub 2021 May 25.
7
Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
J Biomol Struct Dyn. 2022 Jun;40(9):3899-3906. doi: 10.1080/07391102.2020.1851305. Epub 2020 Nov 30.
8
Allergen fragrance molecules: a potential relief for COVID-19.
BMC Complement Med Ther. 2021 Jan 21;21(1):41. doi: 10.1186/s12906-021-03214-4.

引用本文的文献

3
and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2.
Pharmaceuticals (Basel). 2022 Apr 25;15(5):530. doi: 10.3390/ph15050530.
7
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning.
Comput Struct Biotechnol J. 2021;19:3133-3148. doi: 10.1016/j.csbj.2021.05.037. Epub 2021 May 24.

本文引用的文献

2
Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M.
Signal Transduct Target Ther. 2020 May 9;5(1):67. doi: 10.1038/s41392-020-0178-y.
3
Enhanced reactivity of twisted amides inside a molecular cage.
Nat Chem. 2020 Jun;12(6):574-578. doi: 10.1038/s41557-020-0455-y. Epub 2020 Apr 20.
4
Structure of M from SARS-CoV-2 and discovery of its inhibitors.
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
5
Molecular Architect: A User-Friendly Workflow for Virtual Screening.
ACS Omega. 2020 Mar 20;5(12):6628-6640. doi: 10.1021/acsomega.9b04403. eCollection 2020 Mar 31.
6
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Science. 2020 Apr 24;368(6489):409-412. doi: 10.1126/science.abb3405. Epub 2020 Mar 20.
7
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.
Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0. eCollection 2020.
8
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012.
9
COVID-19: a novel coronavirus and a novel challenge for critical care.
Intensive Care Med. 2020 May;46(5):833-836. doi: 10.1007/s00134-020-05955-1. Epub 2020 Mar 3.
10
Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis approach.
J Med Virol. 2020 Jun;92(6):632-638. doi: 10.1002/jmv.25743. Epub 2020 Mar 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验